Rigaku Pharma Forum 2022 for Advanced Analytical Solutions Used in Industry and Research

Rigaku is proud to be hosting the inaugural Pharma Forum, a free-to-attend, two-day virtual event from April 27-28, 2022. The forum examines a range of analytical techniques and how these can be applied during the development, formulation, and manufacture of pharmaceuticals. The event is relevant to anyone involved in analyzing pharmaceuticals, and will feature presentations from industry, academia and Rigaku experts, who will share their thoughts and experiences.

Image credit: Rigaku 

The forum will feature insightful presentations from industry heavyweights such as GSK, BASF, Merck and Nanomi. These will be augmented by presentations from research groups across Europe, USA and Israel as well as by Rigaku experts.

Presentations will address various analytical aspects of pharmaceuticals from the initial stages of drug development, structural elucidation of Active Pharmaceutical Ingredients (APIs), behavior of APIs and excipients in response to external stimuli such as temperature and humidity, all the way to the structure of tablets and pills and rapid identification of pharmaceuticals.  

The theory and application of a range of analytical techniques will be presented, including:

  • Crystallographic structure determination by single-crystal X-ray diffraction (SC-XD) –
  • Crystallographic structure determination of nanocrystals too small for SC-XRD using electron diffraction (ED)
  • Behavior of APIs under specific conditions and interactions with excipients, as well as determination of PDF (pair distribution function), polymorphism, crystallinity, amorphous content and phase composition by powder X-ray diffraction
  • Nanoparticle characterization by small angle X-ray scattering (SAXS) investigation of changes under different environments and polymorphic changes by thermal analysis – including several techniques such as DSC (differential scanning calorimetry) and TGA (thermogravimetric analysis)
  • Rapid phase identification by Raman
  • Non-destructively investigation of structure and integrity of pharmaceuticals by computed tomography (CT)

To attend this free event, please register at  https://www.rigaku.com/forum/pharma2022/.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Rigaku Corporation. (2022, April 04). Rigaku Pharma Forum 2022 for Advanced Analytical Solutions Used in Industry and Research. AZoLifeSciences. Retrieved on November 21, 2024 from https://www.azolifesciences.com/news/20220404/Rigaku-Pharma-Forum-2022-for-Advanced-Analytical-Solutions-Used-in-Industry-and-Research.aspx.

  • MLA

    Rigaku Corporation. "Rigaku Pharma Forum 2022 for Advanced Analytical Solutions Used in Industry and Research". AZoLifeSciences. 21 November 2024. <https://www.azolifesciences.com/news/20220404/Rigaku-Pharma-Forum-2022-for-Advanced-Analytical-Solutions-Used-in-Industry-and-Research.aspx>.

  • Chicago

    Rigaku Corporation. "Rigaku Pharma Forum 2022 for Advanced Analytical Solutions Used in Industry and Research". AZoLifeSciences. https://www.azolifesciences.com/news/20220404/Rigaku-Pharma-Forum-2022-for-Advanced-Analytical-Solutions-Used-in-Industry-and-Research.aspx. (accessed November 21, 2024).

  • Harvard

    Rigaku Corporation. 2022. Rigaku Pharma Forum 2022 for Advanced Analytical Solutions Used in Industry and Research. AZoLifeSciences, viewed 21 November 2024, https://www.azolifesciences.com/news/20220404/Rigaku-Pharma-Forum-2022-for-Advanced-Analytical-Solutions-Used-in-Industry-and-Research.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.